Objective: Accumulating evidence suggests that brain inflammation, elicited by epileptogenic insults, is involved in epilepsy development. Noninvasive nuclear imaging of brain inflammation in animal models of epileptogenesis represents a diagnostic in vivo approach with potential for direct translation into the clinic. Here, we investigated up-regulation of the translocator protein (TSPO) indicative of microglial activation by serial [
| INTRODUCTION
Experimental and clinical evidence indicates that prolonged brain inflammation, triggered by epileptogenic insults and insufficiently controlled by endogenous anti-inflammatory mechanisms, is probably involved in epilepsy development.
1,2 Activation of microglia is one typical characteristic of brain inflammation during insult-induced epileptogenesis, 1 also representing a potential target for diagnostics 3 or pharmacological epilepsy prevention. Quantitative in vivo assessment of microglial activation can be achieved by positron emission tomography (PET) imaging with radiolabeled ligands of the translocator protein (TSPO), which is predominantly expressed by activated microglia during brain inflammation. 4 As serial imaging with dedicated small animal PET scanners has become an available technique also for laboratory rodents, 3, 5 TSPO
PET represents a noninvasive and quantitative tool with high translational potential. In line with recent studies using different rat epilepsy models and TSPO tracers, [6] [7] [8] we recently elucidated the detailed spatiotemporal profile of microglial activation during epileptogenesis in the widely used pilocarpine rat model of temporal lobe epilepsy by longitudinal TSPO PET imaging with the ligand [ 11 C] PK11195 and complementary in vitro techniques. 9 Furthermore, a recent paper demonstrates the predictive potential of TSPO PET at epilepsy onset in a rat model of temporal lobe epilepsy. 10 However, TSPO PET imaging studies in mouse models of epilepsy are still lacking.
In the present study, we utilized the latest generation TSPO tracer [ 18 F]GE180, which is characterized by an improved binding potential and signal-to-noise ratio, 11 for microglial imaging in the intrahippocampal kainate poststatus epilepticus (SE) mouse model of temporal lobe epilepsy. In contrast to the aforementioned rat models, epileptogenesis in this model is induced by unilateral kainate injection into the hippocampus resulting in a self-limiting, primarily nonconvulsive SE. The intrahippocampal kainate mouse model comprises many features of human mesial temporal lobe epilepsy and is among the currently used animal models of the National Institutes of Healthfunded Epilepsy Therapy Screening Program (https:// panache.ninds.nih.gov/CurrentModels.aspx). Besides a circumscribed epileptic focus with typical histopathological representation of hippocampal sclerosis, it is characterized by a short (2-3 weeks) but clear latent phase followed by the emergence of frequently occurring paroxysmal discharges in the chronic phase of the disease, [12] [13] [14] as well as depressionlike comorbidity and pharmacoresistance, [15] [16] [17] making it a suitable model for studying therapeutic interferences for epilepsy prevention. Importantly, activation of brain microglia and astrocytes as well as overexpression of pro-inflammatory mediators, persisting into the chronic phase of epilepsy, have been revealed by ex vivo techniques. 18, 19 We here utilized longitudinal TSPO PET for imaging of microglial activation in the intrahippocampal kainate mouse model, including the characterization of mice undergoing only sham surgery, with the objectives of gaining further insight into microglial activation during epileptogenic processes, estimating the potential contribution of surgeryinduced neuroinflammation, and providing data on a suitable timeframe for anti-inflammatory intervention.
| MATERIALS AND METHODS

| Animals
Male NMRI mice were purchased from Charles River Laboratories (Sulzfeld, Germany) at the age of 7 weeks, and housed in groups of 9 in individually ventilated cages under a 14/10-hour light/dark cycle, with standard laboratory chow (Altromin 1324; Altromin Spezialfutter, Lage, Germany), with water freely accessible. Prior to the beginning of experiments, animals were allowed to adapt to housing conditions and repetitive handling for at least 1 week. • Microglial activation clearly occurs also after sham surgery, suggesting a potential 2-hit insult that drives epileptogenesis in this model were formally approved by the responsible local authority (reference number 14/1441). Animals were randomly added to experimental groups, and all efforts were made to minimize pain, suffering, and the number of animals. The principles outlined in the ARRIVE guidelines and the Basel declaration including the 3R concept have been considered when planning and reporting the experiments.
| Intrahippocampal kainate injection
Induction of SE by intrahippocampal kainate injection was performed according to a previously described protocol. 20 Shortly, kainate monohydrate (0.21 lg in 50 nL saline; Sigma-Aldrich, Steinheim, Germany) was stereotaxically injected over 1 minute into the right CA1 region of the dorsal hippocampus (n = 30) of the isofluraneanesthetized mice using a 0. dissolved in 1 mL acetonitrile was added, followed by 10 minutes of heating at 100°C. After cooling, the crude product was purified by high-performance liquid chromatography (Hichrom, Reading, UK). The purified fraction was diluted with water, and adsorbed on a tC18 Sep-Pak cartridge (Waters, Milford, MA, USA). Following a washing step with water, the product was eluted from the cartridge with anhydrous ethanol (0.5 mL). The molar specific activity of [ 18 F]GE180 ranged from 444.8 to 588.6 GBq/lmol, which corresponds to a specific activity from 1288.4 to 1705.6 GBq/lg. The concentration was 0.24 AE 0.02 lg/mL (0.70 nmol/mL AE 0.06 nmol/mL). For administration, the ethanol solution of [ 18 F]GE180 was diluted with saline.
| PET imaging procedure
Kainate-injected mice (n = 12) were subjected to [ 18 F] GE180 PET scans at 2 days (n = 5), 5-7 days (n = 6), 2 weeks (n = 5), 3 weeks (n = 8), 7 (n = 7), and 14 weeks (n = 7) after SE. Saline-injected mice (n = 14) were imaged by [ 18 F]GE180 PET 2 days (n = 6), 7 days (n = 8), 2 weeks (n = 6), 3 weeks (n = 6), 7 weeks (n = 8), and 14 weeks (n = 6) after sham surgery. Due to practicability, not all animals were scanned at all time points. Some of the saline-injected (n = 7) and kainateinjected (n = 10) mice were scanned before SE. All imaging procedures were carried out under inhalational isoflurane anesthesia (1.5%-2.5% at an oxygen flow of 0.6 L/min) with continuous monitoring of respiration (BioVet software; m2m Imaging, Cleveland, OH, USA). PET images were acquired using a dedicated small animal PET/computed tomography (CT) camera (Inveon PET/CT; Siemens Healthcare, Erlangen, Germany). Mice were positioned prone in a 2-mouse imaging chamber (Minerve, Esternay, France), with the brain at the center field of view. [ 18 F]GE180 (12.30 AE 1.63 MBq) was injected in a volume of 0.15 mL via a custom-made catheter inserted into a lateral tail vein. After a 20-minute uptake period under anesthesia, a static PET acquisition was performed over 40 minutes. Images were reconstructed using an iterative OSEM3D/fastMAP (ordered subset expectation maximization 3-dimensional/maximum a posteriori) algorithm with corrections for decay, attenuation, random events, and scatter. For attenuation correction, a 20-minute 57
Co transmission scan was used. To obtain anatomical information for image analysis, a fast low-dose CT scan was performed after PET imaging.
| PET image analyses
PET images were coregistered to a magnetic resonance imaging (MRI) template 22, 23 using PMOD software (PMOD Technologies, Z€ urich, Switzerland). For this purpose, CT images were matched to the MRI template and subsequently mapped to their corresponding PET images. A region of interest (ROI) atlas based on the MRI template was then applied to the coregistered images. Individual MRI cannot be performed in our laboratory. However, morphological brain changes in the intrahippocampal kainate model in mice typically occur more toward the chronic disease phase. For instance, Bouilleret et al. 12 and
Zattoni et al. 19 show that the general morphology of the hippocampus as a whole is still preserved until at least 15 days after kainate injection. As major inflammation occurred 5-7 days after kainate injection in the present study, these time points are probably not affected by major structural brain changes. GE180 uptake between baseline and each time point after SE or after sham injection as well as between kainate-and saline-injected mice were analyzed by a 2-sample unpaired t test using SPM 12 software (UCL, London, UK). A significance level threshold of .01 (uncorrected for multiple comparisons) and a minimum cluster size of 10 voxels were selected. Parametric t maps resulting from each comparison were imported into PMOD, and the threshold was set individually to the corresponding t value. Activated voxels were anatomically located by coregistration with the MRI template.
| Statistics
All data are presented as mean AE standard deviation. Statistical analyses were performed using Prism7 (GraphPad Software, La Jolla, CA, USA (Figures 1 and 2) . Following sham surgery with saline injection, elevated tracer uptake became evident between days 2 and 7 in all F]GE180 uptake also found in the sham group throughout the brain at 2 to 7 days postsurgery. Data are presented as mean AE standard deviation with a group size of n = 17 at baseline and n = 5-8 at all further time points in the SE and sham groups. Statistical analysis of SE versus sham group at the respective time point was performed by 1-way analysis of variance (ANOVA) and Sidak multiple comparisons test (*P < .05). Intragroup differences versus baseline were calculated by 1-way ANOVA and Dunnett's multiple comparisons test (red #P < .05, SE group; blue #P < .05, sham group) analyzed ROIs except for the ipsilateral amygdala without differentiation in peak inflammation between analyzed regions (Figure 2 ). Interestingly, in the amygdala decreased values were seen at 21 days (ipsilateral; 1.04 AE 0.12%ID/ cc vs baseline 1.23 AE 0.11%ID/cc, P = .02) and again 14 weeks postsurgery (ipsilateral, 0.94 AE 0.17%ID/cc vs baseline 1.23 AE 0.11%ID/cc, P < .001; and contralateral, 0.94 AE 0.17%ID/cc vs baseline 1.20 AE 0.14%ID/cc, P = .004). No statistically significant differences were found when comparing ipsi-and contralateral hemispheres for analyzed ROIs.
After SE induced by kainate injection, maximum increase in tracer uptake compared to baseline was evident in the ipsilateral dorsal hippocampus at days 5-7 (2.17-fold, 1.77 AE 0.28%ID/cc vs baseline 0.82 AE 0.12%ID/cc, P < .001; Figures 1 and 2) . Ipsilateral peak increase in the other ROIs amounted to 1.64-fold (ventral hippocampus, P < .001), 1.58-fold (thalamus, P < .001), 1.23-fold (amygdala, P = .03), and 1.44-fold (cortex, P < .001). A continuously increased tracer uptake compared to baseline was detected until 7 weeks after SE only in dorsal ipsilateral hippocampus. In all further investigated ROIs, statistically significant increase of tracer uptake was no longer reached at 21 days after SE, but reoccurred in several ROIs at 7 weeks, declining again thereafter. The cerebellum did not show significantly increased values compared to baseline. On the contralateral side, the time course of microglial activation was similar to the ipsilateral hemisphere but the increase of tracer signal compared to baseline was less pronounced. Comparison between ipsi-and contralateral sides resulted in statistically significant differences only at days 5-7 after SE in dorsal hippocampus (P = .04).
Comparison of kainate-and saline-injected groups showed significant differences in ipsilateral dorsal and ventral hippocampus between 2 days and 7 weeks, with the highest increase (1.66-fold) at 5-7 days in dorsal hippocampus (kainate 1.77 AE 0.28%ID/cc vs saline 1.06 AE 0.18% ID/cc, P < .001; Figure 2 ). In all further investigated ROIs, higher values were observed only at single later time points in the ipsilateral hemisphere. On the contralateral side, increase in tracer uptake values for more than a single time point was only found in the dorsal hippocampus (Figure 2 ). Calculation of SUV (grams per cubic centimeter) generally confirmed the results described above, although single comparisons no longer reached statistical significance due to increased variation (data not shown).
| SPM analysis of [ 18 F]GE180 uptake
When comparing each time point after sham surgery with baseline, SPM analysis revealed microglial activation of various cortical, thalamic, and temporal areas including both hemispheres to a similar extent ( Figure 3A) . Nevertheless, maximum activation occurred at 2-7 days after sham surgery around the injection track, which remained affected until 7 weeks postsurgery.
Comparison of each time point after kainate injection with baseline revealed microglia activation at 2-7 days after SE in almost the entire mouse brain ( Figure 3B ). From 14 days until 7 weeks after SE, predominantly ipsilateral cortex and hippocampus showed high t values, whereas contralateral cortex and hippocampus were affected to a lesser extent. At 14 weeks, significant neuroinflammation persisted only in ipsilateral cortex and hippocampus.
Comparison between mice after SE and mice after sham surgery resulted in a clear peak of inflammation at 5-7 days ( Figure 3C ). Although also involving some cortical areas, the inflammation was mainly restricted to the ipsilateral hippocampus. Interestingly, a second peak of hippocampal inflammation was seen at 7 weeks after SE, as already suggested by ROI analysis.
| DISCUSSION
In the present study, quantitative longitudinal noninvasive [ 18 F]GE180 PET imaging revealed persisting TSPO upregulation indicative of brain inflammation during and after SE-initiated epileptogenesis in the intrahippocampal kainate mouse model. Microglial activation reaches its peak within 1 week after SE and is not only limited to the ipsilateral hippocampus but spreads to further epilepsy-associated brain regions. Importantly, microglial activation clearly occurs also after sham surgery, suggesting a 2-hit insult that potentially drives epileptogenesis in this model.
Recent experimental studies by us and others have demonstrated the feasibility of longitudinal PET imaging of TSPO to identify epileptogenesis-associated inflammatory processes in the rat brain. 6, 8, 9 Similar to the findings in the present study, TSPO up-regulation was evident within days and for a few weeks after SE-induced epileptogenesis, which was confirmed by in vitro autoradiography and immunohistochemistry. When comparing [ 18 F]GE180 brain uptake before and following SE, up-regulated TSPO expression reflecting predominantly microglial activation 4, 24 was evident in the ipsilateral hippocampus between 2 days and 7 weeks after SE, peaking at about 5-7 days after SE. This quantitative time profile is in accordance with previous immunohistochemical studies in the intrahippocampal kainate mouse model, revealing microglial activation in the injected hippocampus between 3 days and at least 21-28 days after SE 18, 19 as well as at >6 weeks after SE. 25 In the intrahippocampal kainate mouse model, high-voltage sharp waves, EEG events representing epileptiform activity, have been recorded not only in the ipsilateral but also in the contralateral hippocampus. 14, 25 This involvement of the contralateral hippocampus in seizure generation and/or progression is well in line with the enhanced TSPO expression that was observed in the contralateral hippocampus, albeit to a lesser extent than in the ipsilateral hippocampus. These data are also substantiated by previous immunohistochemical assessments detecting microglial activation in the hippocampus contralateral to the injection site at 3 days after SE 18 and at >6 weeks after SE. 25 Interestingly, our timeline revealed a second, less pronounced peak of microglial activation in epilepsy-associated brain regions at 7 weeks after SE, which might reflect accelerated disease progression around this time point. This less pronounced peak was not caused by increased data variation due to scanning of different cohorts, as all mice scanned between 21 days and 7 weeks after SE were identical. Additional calculation of SUV from PET imaging data resulted in comparable findings. Nonetheless, data variation was increased by SUV calculation, which led to loss of single statistically Here, we used a static 40-minute imaging protocol instead of dynamic scanning, allowing for kinetic modeling. This protocol was established because the longitudinal design of the study prohibited the generation of arterial blood sample-based input function, and it was not possible to extract a reliable image-derived input function. A reference tissue model using thalamus as reference region was recently published 27 that could not be applied in our study, Following SE induced by intrahippocampal kainate injection, almost all mice develop epileptiform EEG activity after a latent period varying between 3 and 14 days in duration, 14, 25, 32 whereas tracer uptake was found to reapproach baseline levels in both the ipsilateral and the contralateral hippocampus only between 7 and 14 weeks after SE. This indicates that ongoing neuroinflammation is present long after onset of seizure activity. In accordance, a recent TSPO PET imaging study in temporal lobe epilepsy patients demonstrated increased tracer volume of distribution ipsilateral and contralateral to the seizure focus compared to healthy control subjects. 33 The TSPO signal both during early epileptogenesis and during chronic epilepsy has been shown to correlate with seizure frequency in 2 rat post-SE models. 6, 34 As no seizure analysis was performed in the current study, any potential correlation between neuroinflammation and seizure outcome remains an open question for further studies. Moderate increases in TSPO expression were also apparent in the ipsilateral thalamus. To our knowledge, no inflammatory processes have been described to occur in the thalamus in this model thus far. However, it seems reasonable to assume that the thalamus may be partially affected considering that thalamic nuclei have been suggested to be involved in seizure initiation and spread in human temporal lobe epilepsy, 35 and to be subject of blood-brain barrier leakage in animal models of epileptogenesis. [36] [37] [38] Moreover, increased TSPO signal in the thalamus was observed in post-SE rat models. 8, 9, 39 As the process of intrahippocampal injection represents a traumatic brain injury in itself potentially resulting in inflammatory reactions, we included a detailed evaluation of mice after sham surgery. These reactions include microglial activation and blood-brain barrier leakage, 19, 40, 41 representing pro-epileptogenic brain alterations in experimental models. 2, 42 In our study, saline-injected mice did not exhibit signs of SE, but moderate increases in TSPO expression compared to baseline values were evident throughout the brain for approximately 1 week after surgery. This is an important issue to be considered for all studies including brain microinjection. Severe penetrating traumatic brain injury is associated with later epilepsy development in a major proportion of clinical patients, 43, 44 and mild traumatic brain injury is also associated with an increased risk for unprovoked epileptic seizures. 45, 46 As revealed by the SPM analysis, the extent of significantly changed voxels after kainate injection (vs baseline) is much more prominent than after sham surgery (vs baseline) and after SE (vs sham) taken together, suggesting an additive contribution to brain inflammation, and potentially to epileptogenesis. Doubtlessly, however, proving the extent of contribution of sham surgery to epileptogenesis will be impossible, as kainate injection cannot be performed without a limited brain insult. In this regard, a recent paper on harmonization of video-EEG recording in rodents suggests that electrode implantation might lead to potentially epileptogenic brain lesions. 47 Nevertheless, sham surgery alone did not lead to spontaneous recurrent convulsant or electrographic seizures in this model. 14, [48] [49] [50] In the current study,
we decided against individual EEG-based SE monitoring. Implantation of electrodes represents an additional inflammation-inducing insult, which might interact with epileptogenesis-associated inflammation and therefore might hamper the interpretation of the results.
| CONCLUSION
In this study, we provide further evidence that longitudinal PET imaging measuring TSPO in vivo up-regulation reliably identifies the spatiotemporal profile of epileptogenesis-associated brain inflammation. This paves the way for future studies investigating in vivo imaging of brain inflammation as a predictive biomarker in experimental models in which only some of the animals develop epilepsy. In the intrahippocampal kainate mouse model, neuroinflammation was most strongly evident in the ipsilateral hippocampus but also in the contralateral hippocampus and other epilepsy-related brain regions between 2 days and at least 7 weeks after SE. Importantly, the traumatic surgical insult contributes significantly to the total inflammatory burden during early epileptogenesis. The demonstrated time course of neuroinflammation will help identify appropriate time points for inflammation-targeted, potentially antiepileptogenic therapy.
